Generics - Financial, Research

Filter

Current filters:

FinancialResearch

Popular Filters

Cipla to invest £100 million in its UK subsidiary

Cipla to invest £100 million in its UK subsidiary

07-07-2014

Indian drugmaker Cipla has decided to make a significant investment in its UK subsidiary over the next…

CiplaFinancialGenericsMarkets & MarketingResearchUK

Cadila net profit up by 82% in third-quarter

07-02-2014

Indian drugmaker Cadila Healthcare posted a net profit of 1.86 billion rupees ($29.7 million), for the…

BiosimilarsCadila PharmaceuticalsFinancialGenericsResearchZydus Cadila

Pharmstandard commits $30 million to Argos Therapeutics; post 1st-half results

28-08-2013

Russia's largest drugmaker Pharmstandard (PHST: RU) that its subsidiary Pharmstandard International.(Luxembourg)…

AGS-003Argos TherapeuticsFinancialGenericsOncologyPharmaceuticalPharmstandardResearch

Indian citizens lack free access to essential generic medicines, while policies risk undermining new drug research funding

17-07-2013

Modern India has the third largest national economy in the world in purchasing power adjusted terms.…

Asia-PacificFinancialGenericsHealthcarePatentsResearch

Teva fleshes out restructuring plan; licenses Xenon pain drug for $376 million

12-12-2012

Teva Pharmaceutical Industries (NYSE: TEVA's new chief executive Jeremy Levin has outlined the company's…

CopaxoneFinancialGenericsLicensingPatentsPharmaceuticalResearchTeva Pharmaceutical IndustriesXenon Pharmaceuticals

BRICS bringing new resources to health and development as other donors lag

26-03-2012

So-called BRICS countries, comprising Brazil, Russia, India, China and South Africa, are injecting new…

FinancialGenericsGlobalHealthcarePharmaceuticalResearch

European Medicines Agency’s 2012 work program and budget

18-12-2011

The European Medicines Agency’s Management Board, at its meeting on 15 December 15, adopted the…

BiotechnologyEuropeFinancialGenericsPharmaceuticalRegulationResearch

Back to top